Ricevi le ultime notizie sulle azioni Xeris Biopharma Holdings con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di XERS

Ultime notizie per

XERIS BIOPHARMA HOLDINGS INC

Xeris Biopharma Holdings

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings Inc

News

Management

Press Releases

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Xeris Biopharma Reports Record First Quarter 2025 Financial Results

Xeris Announces Details for Analyst & Investor Day

Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day

Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025

Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance

Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®

American Regent® Launches Gvoke VialDx™ (glucagon injection)

Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ANAB

DSGN

HLXA

PSTX

XERS

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

ANI Pharmaceuticals

ATAI Life Sciences

Avadel Pharmaceuticals plc - Ordinary Share

Avadel Pharmaceuticals

BGM Group

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cronos Group

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences Hldgs

Harrow

Innoviva

LENZ Therapeutics

Maze Therapeutics

Nektar Therapeutics

Nuvation Bio

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Pacira BioSciences

Pharvaris

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Tilray Brands

Trevi Therapeutics

Wave Life Sciences Ltd. - Ordinary Shares

Comments

Xeris Biopharma Holdings Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO